A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
Conditions
Obesity · Overweight · Type 2 Diabetes Mellitus (T2DM)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Yan'an University Xianyang Hospital, Xianyang, Shaanxi, China
The First Affiliated Hospital of Ningbo University(Ningbo First Hospital), Ningbo, Zhejiang, China
Peking University People's Hospital, Beijing, China
Jinan Central Hospital, Jinan, China
Hebei Petro China Central Hospital, Langfang, China
Luoyang Third People's Hospital, Luoyang, China
Shanghai Tenth People's Hospital, Shanghai, China
Shanghai East Hospital, Shanghai, China
Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Shanghai Fifth People's Hospital Affiliated to Fudan University, Shanghai, China
Hebei Medical University - The Second Hospital, Shijiazhuang, China
Zibo Municipal Hospital., Zibo, China
Study leads
Clinical Trials
Study Director
Hoffmann-La Roche